pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-302b |
Genomic Coordinates | chr4: 112648485 - 112648557 |
Description | Homo sapiens miR-302b stem-loop |
Comment | None |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-302b-5p | ||||||||||||||||||||||||||||||
Sequence | 11| ACUUUAACAUGGAAGUGCUUUC |32 | ||||||||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||||||||
Experiments | Cloned | DRVs in miRNA |
|
||||||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||||||||
Putative Targets |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | FPGT | ||||||||||||||||||||
Synonyms | GFPP | ||||||||||||||||||||
Description | fucose-1-phosphate guanylyltransferase | ||||||||||||||||||||
Transcript | NM_003838 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on FPGT | |||||||||||||||||||||
3'UTR of FPGT (miRNA target sites are highlighted) |
>FPGT|NM_003838|3'UTR 1 AGATATTTTAAATATTGTACACTTTGCCTTTTTGAGTAACATTCCAGAGATAGGTATTTTTTGTAGGCTGTTTCACTGAA 81 CTCAGTTAATGAAAACTGTATTAACATAATTGTTGTAGCATAATATTAATAGTGCAAAAGTACATATAAGTCATTTTGAT 161 GAAAAATATTCCAAGACTAAGTTGAGAAAAGAGATACTATTTTGGATGTGTATCAGTATTTTTGTTTTTAATAATGATTG 241 ATTTGTGGAGCATTGTTTTTTCACATAATTAGTTTTAAAGGTAATTTTCTAAGCATACCTTTGGAATTTTTCCATCTTTT 321 TTGAGGCTTTTGGTCCAGTGAAGTTCTAAGTATTCACTGGCACTTCTCTCCTCAACTGTAATTCTATTTTTAATAATAAA 401 AATGGCATACTGTAGGGTCTTCAGAGTAGTGTAGGAATACTGTAGAAATACTTTTTCAGAAACGAATCCATAGCTGACAA 481 ATTCACTCAGTGCCCAATATATTGTGATTATTTTCGTTGATAAAGAACTAGATACAAAGACCTCTGAAATTGATGATAAA 561 ATTTGTATCTCATTAATTTTATCAAAATGAAACTAAAAGTACATATGTATTATACACTTGAACATGTGTTTGTATATCTT 641 TAAAATTTTCCTTTATGTTCCATTCCATAGGAAAACACACATATGCACACAAAACTCAGTTATCTGTGGGGAAAGTGGTA 721 GTAATAATTGAGATTCATCAATAATCATATAATTTCACTATAGACATTACTTGCATTATCTCCTATCAGTCCTTCTAACA 801 AAACTTCAATTACCAGATGAACTGACTTTAGTTTTCATCTTATTTTTTGTCCACATGCTGGTGATGCTGAGAAACAATAA 881 TTGGCCCAAATGCAGACATCAAGAAGCAGGCAGGAAAATGGAAAAACTGAGATAATACACAGGTGATAAACAGTTTCGAG 961 AAAATAAAAATTGGCTAGAATCTCAAGTTATGTGTTTCTATATTGGTATAAGCATATAAGTGAAAAGTCTTATAAGTGTA 1041 ATAGAGAAAAGATTTGTCAGTGTGTTTTTTTAAATGAAATAACTAGTCTGTGCTACTTTATGTCAATATAAAAATTGGTA 1121 AACTAGAAGTAACTTGTCCACAACCCTCAGTTATGATACTTATGTGCGTGTTTTTTTTTCCAAAGTTTTTCCCAAGGAGA 1201 AGATACAAATATATGGTAGCTATTGTTTAAAAATGATTGATTTACTTGCAGATTTTTCAGAGGATGTTATGTCTTTGTCA 1281 TTCATTAAATGTTCAAAATTGTAGTTTTACCAAATCTGAAGTGCCATCAGTTATAAGAATCACCATTATTTTATGTTCCA 1361 TTAAGAAAAACACAATAAAACATGACACTGCTTTTTTTGTTACTTGAAATTTTCATATTTATTGGAGAGCTCTTTTAGAT 1441 GTTTTTAAATACAGATTTTTATTTAACCCTCTTGCATATACATATAAAATAACAAAAAAATAAAATATTGAGATATCATC 1521 AAGAAATTTCTACAGCTTCACATTCAAACTCTTCAGCACTTTCAGAGCTATTGATATGCATATGTCCACCTAGTACCATC 1601 TTCTCTGCTTTCAGAATTATTGGTAAGGCTGCATTTCCTGAGTGCTCTACCACACTTATGTCTGGATTTTTTTTACCCAG 1681 CTACAGACCCACACTCCTGCAAGATTTGATACCCTTCTATTTGGCAAAACTCAGTTTCACTTTTCTTTCAGTTTAATCAC 1761 AGGTCCTTAGAAGATCGGACCTGTGATTCTATTCAAAGTCAGAAAGAGATTTCTCACAAATTGACGTCATATTAACATGT 1841 CAATATGAAAATTAATTGTTTGGTAAACCAGAAGTGACCTGTCTGAAGCCCTCAATTGTGGTATTTGTGTGTTTGTTTTT 1921 TCTTTTTCAAGATTCTTTTTAAAGAAAATATATGGTAGCTGTTGTTTAACATTTATCTACTTACAGAGCGTTCAGAGGAT 2001 GTTATATGTTTATTAAGTGCTCAATACTGTATTTTAACCTAATCTGAATTTTAATCATAATCCTGTACAATGCATGGATT 2081 CTGGTTGCTTTGAAATGGTTCTGTTCAAAGGACTTATCAATGTCTCTTGCTTTGAGATGTATTGCTTGGTGTGTAGTAGC 2161 ACAAACGTACCACCAATAATGTACCTAATTCAACTGAAGTGACAGTCATATACGCAGATATGACCAAGTTCACATGTGAG 2241 CAAGTAACAACTCCATGACTATTGCTGCCTGGCTAATAGCTATTATACTATCATTTGTAAGGCACATTCTGTTTTCTGGG 2321 GTGTCGAAATGTGGATAAAAAAAGATGAATTAGGAATGATTCTAACCTAAGTATGTGTTTTAATAAAAGGATCTAGGCAA 2401 AAAAAAAAAAAGTAAGTCACTCCTAAATTTAATCCCTGAATAATGCAGTGTACATGATGATAGAGGAGAAGTGTGTTTTT 2481 GATAAGAAGTGACTAAATTTTGTGACAATCTTAATTTTTTAGGCTTTTCATTTAGTCTTCCAATAAAGATAATTTTTTTC 2561 TGAGTTTTATCAGCAGTAGAAAAATAAGACCTACATGGATAAGTTTGAAATTAAACATTTTGTCTCATTTTATAATTTTT 2641 ATTTTTATGAAATCATGGCACTTACATCATATACTCAGGTGTGTAAAAGCCTGCTATTTGTAACTATAATCCATAAACTT 2721 ATTGATGATTTAATAACTATCAACAAGGGCATGGGAAAAATTCAACATTTGATAATAATCTTTTACCTTAGGCATTTATT 2801 CTCTAAGCAAAGCAGAAATAAAGGATATGTATCAGTGTATACTGATTGAAATAAAGCTTTAAAAATCCAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | BC-1 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM796037. RNA binding protein: AGO2. Condition:4-Thiouridine
PAR-CLIP data was present in GSM796038. RNA binding protein: AGO2. Condition:4-Thiouridine
... - Gottwein E; Corcoran DL; Mukherjee N; et al., 2011, Cell host & microbe. |
Article |
- Gottwein E; Corcoran DL; Mukherjee N; et al. - Cell host & microbe, 2011
Primary effusion lymphoma (PEL) is caused by Kaposi's sarcoma-associated herpesvirus (KSHV) and frequently also harbors Epstein-Barr virus (EBV). The expression of KSHV- and EBV-encoded microRNAs (miRNAs) in PELs suggests a role for these miRNAs in latency and lymphomagenesis. Using PAR-CLIP, a technology which allows the direct and transcriptome-wide identification of miRNA targets, we delineate the target sites for all viral and cellular miRNAs expressed in PEL cell lines. The resulting data set revealed that KSHV miRNAs directly target more than 2000 cellular mRNAs, including many involved in pathways relevant to KSHV pathogenesis. Moreover, 58% of these mRNAs are also targeted by EBV miRNAs, via distinct binding sites. In addition to a known viral analog of cellular miR-155, we show that KSHV encodes a viral miRNA that mimics cellular miR-142-3p function. In summary, this study identifies an extensive list of KSHV miRNA targets, which are likely to influence viral replication and pathogenesis.
LinkOut: [PMID: 22100165]
|
CLIP-seq Support 1 for dataset GSM796037 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | BC-1 / 4-Thiouridine |
Location of target site | ENST00000370894.5 | 3UTR | UCAAGAUUCUUUUUAAAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22100165 / GSE32109 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM796038 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | BC-1 / 4-Thiouridine |
Location of target site | ENST00000370894.5 | 3UTR | UCAAGAUUCUUUUUAAAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22100165 / GSE32109 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
109 hsa-miR-302b-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT088427 | LCLAT1 | lysocardiolipin acyltransferase 1 | 2 | 4 | ||||||||
MIRT142406 | TNRC6A | trinucleotide repeat containing 6A | 2 | 2 | ||||||||
MIRT162006 | TFRC | transferrin receptor | 2 | 2 | ||||||||
MIRT170893 | PURB | purine rich element binding protein B | 2 | 2 | ||||||||
MIRT203348 | CCNT2 | cyclin T2 | 2 | 4 | ||||||||
MIRT207353 | TGOLN2 | trans-golgi network protein 2 | 2 | 2 | ||||||||
MIRT208232 | CNBP | CCHC-type zinc finger nucleic acid binding protein | 2 | 4 | ||||||||
MIRT214733 | HSPA9 | heat shock protein family A (Hsp70) member 9 | 2 | 2 | ||||||||
MIRT254842 | NUP50 | nucleoporin 50 | 2 | 2 | ||||||||
MIRT257285 | FOXC1 | forkhead box C1 | 2 | 2 | ||||||||
MIRT338890 | LLPH | LLP homolog, long-term synaptic facilitation | 2 | 2 | ||||||||
MIRT400032 | USP37 | ubiquitin specific peptidase 37 | 2 | 2 | ||||||||
MIRT404031 | ATP9A | ATPase phospholipid transporting 9A (putative) | 2 | 8 | ||||||||
MIRT405843 | EIF2S1 | eukaryotic translation initiation factor 2 subunit alpha | 2 | 2 | ||||||||
MIRT445847 | FPGT | fucose-1-phosphate guanylyltransferase | 2 | 2 | ||||||||
MIRT446350 | EML6 | echinoderm microtubule associated protein like 6 | 2 | 2 | ||||||||
MIRT446649 | BTBD7 | BTB domain containing 7 | 2 | 2 | ||||||||
MIRT447925 | SCRN1 | secernin 1 | 2 | 2 | ||||||||
MIRT448575 | PLCG1 | phospholipase C gamma 1 | 2 | 2 | ||||||||
MIRT463616 | ZBTB33 | zinc finger and BTB domain containing 33 | 2 | 4 | ||||||||
MIRT465782 | TMOD3 | tropomodulin 3 | 2 | 2 | ||||||||
MIRT470261 | PRR14L | proline rich 14 like | 2 | 2 | ||||||||
MIRT471090 | PIK3C2B | phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta | 2 | 2 | ||||||||
MIRT475612 | HMGB1 | high mobility group box 1 | 2 | 2 | ||||||||
MIRT476824 | FNDC3A | fibronectin type III domain containing 3A | 2 | 2 | ||||||||
MIRT483107 | TYRP1 | tyrosinase related protein 1 | 2 | 10 | ||||||||
MIRT500537 | XPO4 | exportin 4 | 2 | 2 | ||||||||
MIRT502525 | EPHA2 | EPH receptor A2 | 2 | 4 | ||||||||
MIRT510989 | PER1 | period circadian clock 1 | 2 | 4 | ||||||||
MIRT512540 | ZNF793 | zinc finger protein 793 | 2 | 4 | ||||||||
MIRT513868 | HOXA5 | homeobox A5 | 2 | 2 | ||||||||
MIRT520756 | TFDP1 | transcription factor Dp-1 | 2 | 6 | ||||||||
MIRT524304 | CTC1 | CST telomere replication complex component 1 | 2 | 8 | ||||||||
MIRT526306 | JAKMIP2 | janus kinase and microtubule interacting protein 2 | 2 | 2 | ||||||||
MIRT526378 | LSAMP | limbic system-associated membrane protein | 2 | 2 | ||||||||
MIRT527438 | COL4A3 | collagen type IV alpha 3 chain | 2 | 2 | ||||||||
MIRT527511 | ZNF134 | zinc finger protein 134 | 2 | 2 | ||||||||
MIRT528068 | HES2 | hes family bHLH transcription factor 2 | 2 | 2 | ||||||||
MIRT528367 | ZMYM1 | zinc finger MYM-type containing 1 | 2 | 4 | ||||||||
MIRT531804 | TFCP2L1 | transcription factor CP2 like 1 | 2 | 2 | ||||||||
MIRT532323 | DUSP4 | dual specificity phosphatase 4 | 2 | 2 | ||||||||
MIRT532431 | DHX33 | DEAH-box helicase 33 | 2 | 2 | ||||||||
MIRT534523 | SAR1A | secretion associated Ras related GTPase 1A | 2 | 2 | ||||||||
MIRT536660 | INIP | INTS3 and NABP interacting protein | 2 | 2 | ||||||||
MIRT538488 | CLOCK | clock circadian regulator | 2 | 2 | ||||||||
MIRT538593 | CDK6 | cyclin dependent kinase 6 | 2 | 2 | ||||||||
MIRT539706 | EIF3H | eukaryotic translation initiation factor 3 subunit H | 2 | 2 | ||||||||
MIRT540306 | GFPT1 | glutamine--fructose-6-phosphate transaminase 1 | 2 | 2 | ||||||||
MIRT546892 | PURA | purine rich element binding protein A | 2 | 2 | ||||||||
MIRT552738 | YRDC | yrdC N6-threonylcarbamoyltransferase domain containing | 2 | 2 | ||||||||
MIRT552781 | YIPF6 | Yip1 domain family member 6 | 2 | 2 | ||||||||
MIRT553742 | TBL1XR1 | transducin beta like 1 X-linked receptor 1 | 2 | 4 | ||||||||
MIRT553909 | SUMO2 | small ubiquitin-like modifier 2 | 2 | 2 | ||||||||
MIRT554540 | RRS1 | ribosome biogenesis regulator homolog | 2 | 2 | ||||||||
MIRT555319 | PPP2CB | protein phosphatase 2 catalytic subunit beta | 2 | 2 | ||||||||
MIRT555512 | PMEPA1 | prostate transmembrane protein, androgen induced 1 | 2 | 2 | ||||||||
MIRT556221 | MB21D2 | Mab-21 domain containing 2 | 2 | 2 | ||||||||
MIRT556292 | MAP3K5 | mitogen-activated protein kinase kinase kinase 5 | 2 | 2 | ||||||||
MIRT556606 | LDOC1L | retrotransposon Gag like 6 | 2 | 4 | ||||||||
MIRT556901 | ISOC1 | isochorismatase domain containing 1 | 2 | 2 | ||||||||
MIRT557675 | GATA6 | GATA binding protein 6 | 2 | 2 | ||||||||
MIRT560198 | GXYLT2 | glucoside xylosyltransferase 2 | 2 | 2 | ||||||||
MIRT560493 | BUB3 | BUB3, mitotic checkpoint protein | 2 | 2 | ||||||||
MIRT566069 | RCC2 | regulator of chromosome condensation 2 | 2 | 2 | ||||||||
MIRT568431 | GDNF | glial cell derived neurotrophic factor | 2 | 2 | ||||||||
MIRT570703 | FAM69A | family with sequence similarity 69 member A | 2 | 2 | ||||||||
MIRT571705 | RPL36A-HNRNPH2 | RPL36A-HNRNPH2 readthrough | 2 | 2 | ||||||||
MIRT573152 | ITGA9 | integrin subunit alpha 9 | 2 | 2 | ||||||||
MIRT574410 | TFAP2A | transcription factor AP-2 alpha | 2 | 2 | ||||||||
MIRT614823 | PVRL4 | nectin cell adhesion molecule 4 | 2 | 2 | ||||||||
MIRT616507 | COX7A2L | cytochrome c oxidase subunit 7A2 like | 2 | 2 | ||||||||
MIRT618301 | COL4A4 | collagen type IV alpha 4 chain | 2 | 2 | ||||||||
MIRT621188 | FAM153B | family with sequence similarity 153 member B | 2 | 2 | ||||||||
MIRT621594 | WT1 | Wilms tumor 1 | 2 | 2 | ||||||||
MIRT623814 | GGCX | gamma-glutamyl carboxylase | 2 | 2 | ||||||||
MIRT624407 | CCDC171 | coiled-coil domain containing 171 | 2 | 2 | ||||||||
MIRT625136 | CKAP2L | cytoskeleton associated protein 2 like | 2 | 2 | ||||||||
MIRT626121 | MRRF | mitochondrial ribosome recycling factor | 2 | 2 | ||||||||
MIRT626874 | AP3B1 | adaptor related protein complex 3 beta 1 subunit | 2 | 2 | ||||||||
MIRT627874 | PAN2 | PAN2 poly(A) specific ribonuclease subunit | 2 | 2 | ||||||||
MIRT633670 | FAM53B | family with sequence similarity 53 member B | 2 | 2 | ||||||||
MIRT634285 | SYAP1 | synapse associated protein 1 | 2 | 2 | ||||||||
MIRT640925 | POU2F1 | POU class 2 homeobox 1 | 2 | 2 | ||||||||
MIRT642028 | MYADM | myeloid associated differentiation marker | 2 | 2 | ||||||||
MIRT643031 | CHCHD7 | coiled-coil-helix-coiled-coil-helix domain containing 7 | 2 | 2 | ||||||||
MIRT646122 | SLC26A9 | solute carrier family 26 member 9 | 2 | 2 | ||||||||
MIRT646245 | SNAP47 | synaptosome associated protein 47 | 2 | 2 | ||||||||
MIRT652457 | TMEM2 | transmembrane protein 2 | 2 | 2 | ||||||||
MIRT657018 | KCNK5 | potassium two pore domain channel subfamily K member 5 | 2 | 2 | ||||||||
MIRT660586 | APP | amyloid beta precursor protein | 2 | 2 | ||||||||
MIRT664316 | CD209 | CD209 molecule | 2 | 2 | ||||||||
MIRT667113 | OLA1 | Obg like ATPase 1 | 2 | 2 | ||||||||
MIRT668773 | DCP2 | decapping mRNA 2 | 2 | 2 | ||||||||
MIRT698430 | TM4SF1 | transmembrane 4 L six family member 1 | 2 | 2 | ||||||||
MIRT700216 | REL | REL proto-oncogene, NF-kB subunit | 2 | 2 | ||||||||
MIRT710498 | CAPRIN1 | cell cycle associated protein 1 | 2 | 2 | ||||||||
MIRT711836 | AMOTL2 | angiomotin like 2 | 2 | 2 | ||||||||
MIRT713226 | GPR75 | G protein-coupled receptor 75 | 2 | 2 | ||||||||
MIRT714415 | TBC1D16 | TBC1 domain family member 16 | 2 | 2 | ||||||||
MIRT714490 | HSPA4 | heat shock protein family A (Hsp70) member 4 | 2 | 2 | ||||||||
MIRT715254 | F9 | coagulation factor IX | 2 | 2 | ||||||||
MIRT716250 | PALM2 | paralemmin 2 | 2 | 2 | ||||||||
MIRT717261 | BMPR2 | bone morphogenetic protein receptor type 2 | 2 | 2 | ||||||||
MIRT717730 | FGF1 | fibroblast growth factor 1 | 2 | 2 | ||||||||
MIRT719262 | CD44 | CD44 molecule (Indian blood group) | 2 | 2 | ||||||||
MIRT719398 | SLC15A4 | solute carrier family 15 member 4 | 2 | 2 | ||||||||
MIRT720653 | TMEM218 | transmembrane protein 218 | 2 | 2 | ||||||||
MIRT720777 | MSANTD3-TMEFF1 | MSANTD3-TMEFF1 readthrough | 2 | 2 | ||||||||
MIRT722059 | TMEFF1 | transmembrane protein with EGF like and two follistatin like domains 1 | 2 | 2 |
miRNA-Drug Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|